• GeneSystem set a private placement of KRW 5.8 billion in 1st tranche, unregistered coupon-bearing unsecured convertible bonds.
• Maturity set for Oct. 8, 2029; zero coupon, 6% yield-to-maturity; redemption at 119.5618% of face value.
• Conversion price set at KRW 4,141 per share; up to 1,400,627 common shares, equal to 16.46% of outstanding shares.
• Conversion window runs from Oct. 8, 2027 to Sept. 8, 2029; proceeds earmarked for investments or loans to expand subsidiaries.
• Investor put begins Oct. 8, 2028 on a quarterly schedule; issuer call runs from Oct. 8, 2027 through Oct. 8, 2028.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GeneSystem Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260930000411), on September 30, 2026, and is solely responsible for the information contained therein.